SENS

Audited Group Financial Results and Cash Dividend Declaration for the year ended 30 June 2021, Date/Time: 2021/08/25 07:05:00


Audited Group Financial Results and Cash Dividend Declaration for the year ended 30 June 2021 Adcock Ingram Holdings Limited (Incorporated in the Republic of South Africa) (Registration number 2007/016236/06) Share code: AIP ISIN: ZAE000123436 ("Adcock Ingram" or "the Company" or "the Group") Audited Group Financial Results and Cash Dividend Declaration For the year ended 30 June 2021 - B-BBEE Level 3 - Revenue Increased 6% - Gross profit declined 2% - HEPS declined 3% - Final dividend 90 cents per share Introduction The Group delivered a resilient performance in the year under review, despite the difficult operating environment, characterised by the continuing adverse impact of COVID-19, the tough economic environment and high levels of unemployment impacting consumer spending. The Group's activities are regarded as essential services and all business units continued operating throughout all levels of lockdowns, while maintaining rigorous monitoring and evaluation of COVID-19 protocols to safeguard our employees and customers. This ensured continuity in producing and supplying medicines, including life-saving products such as intravenous fluids, renal dialysis fluids and ARVs, as well as other acute medicines and hygiene products used to minimise the impact of COVID-19. As the disease spread, the prevalence of infections amongst employees has unfortunately increased, putting certain of the operations at risk of not being able to operate on an uninterrupted basis. All factories and warehouses had to close for certain periods to allow for additional sanitising procedures and testing of employees, but never for more than a few days at a time at most. In addition, global supply constraints, particularly on medicines and active pharmaceutical ingredients from Asia needed to be overcome at various points in the year. We have proven that we can continue to protect our people in the work environment, and maintain financial stability for the Group to continue all of its operations. The business adopted new operational strategies based on the changes in the market, providing a solid foundation for the continuity of operations. The Group experienced good demand for immune-boosting products, certain small-volume parenterals and acute renal dialysis products. Demand was poor for cough, colds and flu medicine (due to the absence of a flu season in South Africa). Low levels of patients consulting doctors and postponement of elective surgeries affected the performance of certain, mainly acute, prescription medicines and ophthalmic surgical products and instruments. Lockdown restrictions also had an impact on many hospital products (due to reduced number of trauma and medical admissions), as well as on shoe care and sun care products. Nonetheless, with the exception of the OTC business unit, which is the largest cough, colds and flu company in South Africa, all business units posted solid trading performances, achieving good growth in turnover, with disciplined cost control and yielding healthy growth in trading profit. Adcock Ingram's strong and adaptable people, and diverse portfolios have proved beneficial in this unprecedented operating environment. In addition, these results could not have been achieved without the support of our customers, partners and suppliers. Change Audited Audited % 2021 2020 Revenue (R'000) 6 7 776 854 7 346 558 Gross profit (R'000) (2) 2 682 775 2 739 056 Trading profit (R'000) (3) 914 610 944 280 Operating profit (R'000) (1) 849 755 862 181 Headline earnings per share (cents) (3) 404.7 417.5 Basic earnings per share (cents) 396.3 398.0 Total assets (R'000) 7 040 418 7 181 750 Net asset value per share (cents) 2 894.7 2 708.6 Interim dividend declared per share (cents) 80.0 100.0 Final dividend declared per share (cents) 90.0 - Segment revenue Consumer (R'000) 42 1 267 287 892 392 OTC (R'000) (16) 1 735 239 2 054 114 Prescription (R'000) 10 3 021 520 2 758 538 Hospital (R'000) 8 1 752 229 1 627 518 Segment trading profit Consumer (R'000) 52 235 380 155 134 OTC (R'000) (31) 292 327 425 747 Prescription (R'000) 3 223 826 217 652 Hospital (R'000) 15 161 385 140 453 Prospects As the effects of the COVID-19 pandemic persist, coupled with the recent civil unrest in the country, the economic outlook for our market remains uncertain and we face the reality of living with COVID-19 restrictions until the vaccines have been widely administered. Although we remain cautious about the effects of COVID-19, the Group has proved its resilience through its diversified portfolio of products and generated solid cash inflows despite the impact of the lockdowns and we are confident of continued value creation for our shareholders. We are supporting our customers where possible to restore their operations following the recent civil unrest in KwaZulu-Natal and Gauteng, so that they are able to continue delivering essential medicine to the people of South Africa. The Group remains committed to expanding its product portfolio in each of its business units. Dividend distribution The Board has declared a final gross dividend out of income reserves of 90 cents per share in respect of the year ended 30 June 2021. The South African dividend tax ("DT") rate is 20% and the net dividend payable to shareholders who are not exempt from DT is 72 cents per share. Adcock Ingram currently has 175 758 861 ordinary shares in issue and qualifying for ordinary dividends. The income tax reference number is 9528/919/15/3. The salient dates for the distribution are detailed below: Last date to trade cum distribution Tuesday, 14 September 2021 Shares trade ex distribution Wednesday, 15 September 2021 Record date Friday, 17 September 2021 Payment date Monday, 20 September 2021 Share certificates may not be dematerialised or rematerialised between Wednesday, 15 September 2021 and Friday, 17 September 2021, both dates inclusive. N Madisa AG Hall Chairperson Chief Executive Officer Approved by the Board: 24 August 2021 SENS release date: 25 August 2021 Company secretary M Phalafala Registered office 1 New Road, Midrand, 1682 Postal address Private Bag X69, Bryanston, 2021 Transfer secretaries Computershare Investor Services Proprietary Limited, Rosebank Towers, 15 Biermann Avenue, Rosebank, Johannesburg, 2196. Private Bag X9000, Saxonwold, 2132 Auditors PricewaterhouseCoopers Inc, 4 Lisbon Lane, Waterfall, 2090 Sponsor Rand Merchant Bank (a division of FirstRand Bank Limited), 1 Merchant Place, corner Fredman Drive and Rivonia Road, Sandton, 2196 Bankers Nedbank Limited, 135 Rivonia Road, Sandown, Sandton, 2146. Rand Merchant Bank, 1 Merchant Place, corner Fredman Drive and Rivonia Road, Sandton, 2196. Investec Bank Limited, 100 Grayston Drive, Sandton, 2146 The full announcement has been published on SENS and is available at https://senspdf.jse.co.za/documents/2021/JSE/ISSE/AIP/AIP022021.pdf The contents of this short-form summary announcement are the responsibility of the Board of Directors. Any investment decision should be considered and based on the content of the information contained in the full announcement and the group annual financial statements which includes the unqualified audit opinion, that will be published on the Company's website at www.adcock.com/investors/financialreports. Copies of the full announcement are available for inspection at the registered office of the Company and may be requested without charge during office hours by phoning +27 11 635 0143. Date: 25-08-2021 07:05:00 Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on, information disseminated through SENS.
[READ MORE]

Conference call to be held on Wednesday, 25 August 2021 at 11:00, Date/Time: 2021/08/18 11:30:00


Conference call to be held on Wednesday, 25 August 2021 at 11:00 Adcock Ingram Holdings Limited (Registration number 2007/016236/06) (Incorporated in the Republic of South Africa) Share code: AIP ISIN: ZAE000123436 (“Adcock Ingram” or “the Company”) CONFERENCE CALL TO BE HELD ON WEDNESDAY, 25 AUGUST 2021 AT 11:00, SUBSEQUENT TO THE RELEASE OF THE ANNUAL FINANCIAL RESULTS Shareholders of Adcock Ingram are advised that the Company is expecting to publish its annual financial results for the year ended 30 June 2021 on Wednesday, 25 August 2021. Accordingly, shareholders are invited to attend a conference call which will be hosted by Mr Andy Hall, Chief Executive Officer and Ms Dorette Neethling, Chief Financial Officer, at 11:00 on Wednesday, 25 August 2021. Interested parties are invited to pre-register for the call at www.adcock.com/Investors/Calendar and follow the link for registration. Alternatively, participants should use the appropriate number from the list below, to dial into the call. Live Call Access Numbers for participants are: Country Access Number Johannesburg: 011 535 3600 Johannesburg ALT: 010 201 6800 UK 0 333 300 1418 USA and Canada: 1 508 924 4326 Other Countries: +27 11 535 3600 Other Countries ALT: +27 10 201 6800 Conference Replay Numbers (72 hours) - Replay Access Code: 40029. Country Access Number South Africa: 010 500 4108 Australia: 073 911 1378 USA: 1 412 317 0088 International: +27 10 500 4108 UK: 0 203 608 8021 Johannesburg 18 August 2021 Sponsor: RAND MERCHANT BANK (A division of FirstRand Bank Limited) Date: 18-08-2021 11:30:00 Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on, information disseminated through SENS.
[READ MORE]

Changes to the composition of board subcommittees, Date/Time: 2021/05/11 14:32:00


Changes to the composition of board subcommittees Adcock Ingram Holdings Limited (Registration number 2007/016236/06) (Incorporated in the Republic of South Africa) Share code: AIP ISIN: ZAE000123436 (“Adcock Ingram” or the “Company”) CHANGES TO THE COMPOSITION OF BOARD SUBCOMMITTEES In compliance with paragraph 3.59 of the JSE Limited Listings Requirements, shareholders are advised that Ms Lulama Boyce has resigned as the chairperson of the Human Resources & Remunerations Committee (RemCom), as a member of the Nominations Committee (NomCom) and as a member of the Audit Committee, with effect from 7 May 2021. Following her appointment to the board of The Bidvest Group Limited (as announced on the Stock Exchange News Service (“SENS”) on 12 March 2021), Ms Boyce was no longer being considered an independent director at Adcock Ingram. Ms Boyce remains a non-executive director of the Company. Furthermore, shareholders are referred to the Company’s SENS announcement of 23 February 2021, which stated that the NomCom would review the composition of the various Board subcommittees, following Mr Lindsay Ralph’s resignation from the Adcock Ingram Board. Consequently, the Board advises shareholders of the following changes to the Board subcommittees, with effect from 7 May 2021: - Ms Mpumi Madisa has been appointed as the chairperson of the NomCom and of the Acquisitions Committee, and as a member of the RemCom; - Prof Matthias Haus has been appointed as the chairperson of the RemCom; - Dr Claudia Manning been appointed as a member of the Audit Committee; - Ms Debbie Ransby has been appointed as a member of the Acquisitions Committee; - Dr Sibongile Gumbi has been appointed as a member of the RemCom; and - Prof Mike Sathekge has been appointed as a member of the NomCom. Midrand 11 May 2021 Sponsor RAND MERCHANT BANK (A division of FirstRand Bank Limited) Date: 11-05-2021 02:32:00 Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on, information disseminated through SENS.
[READ MORE]

General repurchase of shares voluntary announcement, Date/Time: 2021/04/16 07:05:00


General repurchase of shares voluntary announcement Adcock Ingram Holdings Limited (Registration number 2007/016236/06) (Incorporated in the Republic of South Africa) Share code: AIP ISIN: ZAE000123436 ("Adcock Ingram" or the "Company") GENERAL REPURCHASE OF SHARES ANNOUNCEMENT 1. INTRODUCTION Shareholders are advised that, in accordance with the general authority granted by shareholders at the Company’s annual general meeting held on Wednesday, 25 November 2020 ("General Authority"), Adcock Ingram has repurchased from shareholders, through the order book operated by the JSE, and in a series of unrelated transactions without any prior understanding or arrangement between the Company and these shareholders, an additional 5 300 000 ordinary shares ("Shares") in aggregate, representing 3.0% of the Company's issued share capital at the time of the General Authority ("Repurchase"). 2. DETAILS OF THE REPURCHASE Details of the Repurchase are as follows: - Dates of Repurchase: 8 March 2021 – 15 April 2021 Total number of Shares repurchased: 5 300 000 Total value of Shares repurchased: R238.4 million Highest price paid per Share repurchased: R46.05 Lowest price paid per Share repurchased: R43.79 The number of Shares which may still be repurchased by the Company in terms of the General Authority: 3 487 943 The percentage of Shares which may still be repurchased by the Company in terms of the General Authority: 2.0% Shares in issue at the date the General Authority was granted: 175 758 861 Shares in issue currently: 175 758 861 Number of Shares held in treasury after the Repurchase 14 000 000 (including 8 700 000 shares held in treasury prior to the Repurchase) As all the Shares have been repurchased by a wholly-owned subsidiary of the Company, such Shares will not be cancelled but will remain listed and held in treasury. 3. STATEMENT BY THE BOARD The Board has considered the impact of the Repurchase and is of the opinion that for a period of twelve months following the date of the Repurchase: 3.1 the Company and its subsidiaries ("the Group") will be able, in the ordinary course of business, to pay its debts; 3.2 the assets of the Company and the Group will be in excess of the liabilities of the Company and the Group, measured in accordance with the accounting policies used in the latest audited Group annual financial statements; 3.3 the share capital and reserves of the Company and the Group will be adequate for ordinary business purposes; and 3.4 the working capital of the Company and the Group will be adequate for ordinary business purposes. 4. SOURCE OF FUNDS The Repurchase was funded from available cash resources. 5. IMPACT ON FINANCIAL INFORMATION The Group’s cash balances decreased by R239.7 million (including transaction costs of R1.3 million) as a result of the Repurchase and, on elimination of the Repurchase Shares, share capital and share premium will reduce by the same amount. The annual interest charge on the cash required to effect the Repurchase amounts to R9.1 million after tax, assuming an average interest rate of 5.25% paid in the previous financial period. The Repurchase will have the effect of reducing the number of shares in issue used for purposes of the earnings per share and headline earnings per share calculations by an additional 5 300 000, weighted annually according to the dates of Repurchase. Midrand 16 April 2021 Sponsor RAND MERCHANT BANK (A division of FirstRand Bank Limited) Date: 16-04-2021 07:05:00 Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on, information disseminated through SENS.
[READ MORE]
[More]